Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune hypothyroidism]

J L Wémeau1, M d'Herbomez-Boidein

  • 1Clinique endocrinologique, Marc Linquette-USN A, Hôpital Roger-Salengro, CHRU 59037 Lille.

La Revue Du Praticien
|January 9, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Best practices guideline for the use of neck ultrasonography and echo-guided techniques in the management of differentiated thyroid cancers of the follicular type. Société Française d’Endocrinologie.Groupe de Recherche sur la Thyroïde].

Annales d'endocrinologie·2011
Same author

Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndrome.

European journal of endocrinology·2011
Same author

Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular origin.

Annales d'endocrinologie·2011
Same author

Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.

The Journal of clinical endocrinology and metabolism·2011
Same author

Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines.

The Journal of clinical endocrinology and metabolism·2010
Same author

Autoimmune polyendocrine syndrome type 1 in north-western France: AIRE gene mutation specificities and severe forms needing immunosuppressive therapies.

Hormone research in paediatrics·2010
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Acquired hypothyroidism often stems from chronic lymphocytic thyroiditis, an autoimmune condition. Thyroid hormone therapy manages symptoms and reduces autoimmune markers, even with genetic predispositions.

Area of Science:

  • Endocrinology
  • Immunology
  • Pathology

Context:

  • Acquired hypothyroidism is frequently linked to chronic lymphocytic thyroiditis.
  • Autoimmune thyroid disease involves genetic predisposition, T and B lymphocyte cooperation, and cytokine production.
  • Biomarkers for antithyroid autoimmunity are readily accessible.

Purpose:

  • To review the mechanisms and management of acquired autoimmune hypothyroidism.
  • To highlight the role of chronic lymphocytic thyroiditis in thyroid parenchyma reduction and organification defects.
  • To discuss the efficacy of thyroid hormone replacement in managing autoimmune hypothyroid conditions.

Summary:

  • Chronic lymphocytic thyroiditis is a primary cause of acquired hypothyroidism, leading to reduced thyroid function and potential antibody generation.

Related Experiment Videos

  • The autoimmune process involves genetic factors, immune cell interactions, and cytokine release, detectable through available biomarkers.
  • Current treatment focuses on symptomatic relief with thyroid hormone, which corrects hypothyroidism, reduces goiter, and suppresses autoimmune activity.

    • Impact:

    • Understanding the autoimmune basis of hypothyroidism aids in developing targeted diagnostic and therapeutic strategies.
    • Thyroid hormone replacement remains the cornerstone of management, offering comprehensive benefits for patients with autoimmune hypothyroidisms.
    • Advances in identifying biomarkers may lead to earlier diagnosis and personalized treatment approaches for autoimmune thyroid disorders.